(AUPH) Aurinia Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Aurinia Pharmaceuticals | (AUPH) share price targets
Complete technical analysis of Aurinia Pharmaceuticals (AUPH) by charts plus indicators, forecast predictions and share price targets for Aurinia Pharmaceuticals (AUPH)
Aurinia Pharmaceuticals trades in USA in Health Care sector.
10 day averaged volume of Aurinia Pharmaceuticals is 1460060
Date | Daily Closing Price | Open | High | Low | Volume |
03 Fri May 2024 | 5.10 | 5.40 | 5.55 | 5.09 | 1.162 times |
02 Thu May 2024 | 5.17 | 5.68 | 5.79 | 5.03 | 2.355 times |
01 Wed May 2024 | 5.20 | 5.08 | 5.31 | 5.07 | 1.142 times |
30 Tue Apr 2024 | 5.09 | 5.10 | 5.18 | 4.98 | 1.083 times |
29 Mon Apr 2024 | 5.01 | 4.93 | 5.07 | 4.92 | 0.644 times |
26 Fri Apr 2024 | 4.91 | 4.89 | 5.01 | 4.86 | 0.675 times |
25 Thu Apr 2024 | 4.87 | 4.96 | 5.01 | 4.77 | 1.055 times |
24 Wed Apr 2024 | 5.03 | 5.09 | 5.16 | 5.00 | 0.538 times |
23 Tue Apr 2024 | 5.09 | 5.04 | 5.16 | 5.02 | 0.631 times |
22 Mon Apr 2024 | 5.05 | 4.98 | 5.06 | 4.92 | 0.799 times |
Share price targets for Aurinia Pharmaceuticals (AUPH)
Target Type | Value |
Downside Target | 4.71 |
Upside Target | 5.16 |
Upside Target | 5.35 |
Upside Target | 5.41 |
Upside Target | 5.79 |
Upside Target | 5.88 |
Upside Target | 7.53 |
Upside Target | 8.50 |
Upside Target | 9.43 |
Intraday share price targets for Aurinia Pharmaceuticals (AUPH)
Target Type | Value |
Downside Intraday Target | 4.75 |
Downside Intraday Target | 4.4 |
Upside Intraday Target | 5.62 |
Upside Intraday Target | 6.14 |
Upside Intraday Target | 5.27 |
Weekly technical analysis of Aurinia Pharmaceuticals (AUPH)
Date | Weekly Closing Price | Open | High | Low | Volume |
03 Fri May 2024 | 5.10 | 4.93 | 5.79 | 4.92 | 1.727 times |
26 Fri Apr 2024 | 4.91 | 4.98 | 5.16 | 4.77 | 0.77 times |
19 Fri Apr 2024 | 4.99 | 5.09 | 5.23 | 4.71 | 1.069 times |
12 Fri Apr 2024 | 5.10 | 5.05 | 5.26 | 4.95 | 0.926 times |
05 Fri Apr 2024 | 5.05 | 5.00 | 5.41 | 4.97 | 1.497 times |
Price has moved up this week, and volume has increased substantially. This means that the move can continue in coming weeks.
Monthly technical analysis of Aurinia Pharmaceuticals (AUPH)
Date | Monthly Closing Price | Open | High | Low | Volume |
03 Fri May 2024 | 5.10 | 5.08 | 5.79 | 5.03 | 0.238 times |
30 Tue Apr 2024 | 5.09 | 5.00 | 5.41 | 4.71 | 0.911 times |
28 Thu Mar 2024 | 5.01 | 5.73 | 5.88 | 4.85 | 0.451 times |
29 Thu Feb 2024 | 5.72 | 7.62 | 8.50 | 5.35 | 1.415 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Aurinia Pharmaceuticals (AUPH)
Price action analysis of Aurinia Pharmaceuticals ( (AUPH) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Aurinia Pharmaceuticals ( (AUPH) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Aurinia Pharmaceuticals ( (AUPH) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Aurinia Pharmaceuticals ( (AUPH) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Aurinia Pharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a BUY signal for Aurinia Pharmaceuticals in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Aurinia Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Aurinia Pharmaceuticals in short term but SELL signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Aurinia Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 5.08 and Aurinia Pharmaceuticals (AUPH) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Aurinia Pharmaceuticals (AUPH) stock. Volume based technical analysis of Aurinia Pharmaceuticals (AUPH) stock is negative.
Aurinia Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Aurinia Pharmaceuticals ( (AUPH) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Aurinia Pharmaceuticals ( (AUPH) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Aurinia Pharmaceuticals ( (AUPH) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Aurinia Pharmaceuticals ( (AUPH) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Aurinia Pharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a BUY signal for Aurinia Pharmaceuticals in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Aurinia Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Aurinia Pharmaceuticals in short term but SELL signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Aurinia Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 5.08 and Aurinia Pharmaceuticals (AUPH) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Aurinia Pharmaceuticals (AUPH) stock. Volume based technical analysis of Aurinia Pharmaceuticals (AUPH) stock is negative.
Aurinia Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.